Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)

Clinical trial NCT01808638 · COMPLETED

Trial details

NCT number: NCT01808638
Sponsor: Silence Therapeutics GmbH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal

Start date: 2013-03-01
Primary completion: 2015-08-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.